Hak Jae Kim
Papers
1
Total Citations
14
H-Index
1
About
Hak Jae Kim is a leading radiation oncologist whose research centers on precision radiotherapy techniques, particularly stereotactic ablative radiotherapy (SABR) and volumetric modulated arc therapy (VMAT). His most cited work, a 2017 study on gamma analysis with a strict 2%/1 mm criterion for SABR delivered via VMAT, represents a significant contribution to quality assurance in high-precision cancer treatment. This single-institution experience from Seoul National University Hospital established rigorous standards for verifying dose delivery accuracy in stereotactic treatments, directly impacting clinical safety and treatment efficacy. With 14 citations, this paper has influenced how radiation oncology departments implement and evaluate VMAT-based SABR protocols. Kim’s research addresses the critical intersection of technological advancement and clinical application, ensuring that sophisticated radiation delivery systems meet the stringent accuracy requirements necessary for treating small, complex tumor targets. His work at the Institute of Radiation Medicine demonstrates a commitment to advancing radiotherapy quality assurance, making him a respected figure in the field of radiation oncology and a valuable contributor to improving cancer care outcomes through technical innovation.
Research Focus
Key Achievements
Top Papers
- 1